Advertisement

Mount Sinai Receives $4 Million Gift to Support Prostate Health and Urology Department


Advertisement
Get Permission

Mount Sinai has received a $4 million donation from Lizzie and Jonathan Tisch to support prostate health and the Milton and Carroll Petrie Department of Urology at Mount Sinai. The prostate program—founded by Ash Tewari, MBBS, MCh, Kyung Hyun Kim, MD Professor and Chair of Urology—will be named the Lizzie and Jonathan Tisch Center for Prostate Health.

“The Lizzie and Jonathan Tisch Center for Prostate Health is transforming prostate cancer treatment, and we are pleased to continue to support Dr. Tewari’s innovative and important work in helping to treat this disease and improve overall patient care,” said Jonathan Tisch, Co-Chairman of the Board of the Loews Corporation and Chairman and Chief Executive Officer of Loews Hotels & Co.

Improving Treatment and Research

According to the American Cancer Society, one in nine men will be diagnosed with prostate cancer in his lifetime, making it the most common cancer among men other than skin cancer. Although it is a serious disease, prostate cancer is treatable if caught early.

“I am extremely grateful for Lizzie and Jonathan’s ongoing commitment to help better the lives of our patients,” said Dr. Tewari, a world-renowned urologist and prostate cancer specialist. “This gift provides our department with an elevated level of care for patients while also fostering research opportunities for our experts to continue to be pioneers in the field.”

The medical services provided at the Lizzie and Jonathan Tisch Center for Prostate Center include state-of-the-art prostate cancer screening and imaging technologies, precision urology, focal therapy, targeted biopsies, robotics for prostate cancer surgery, prostate cancer fusion biopsy, and active surveillance. The Department of Urology at the Mount Sinai Health System has one of the most robust robotic surgery programs in the country, with Dr. Tewari having performed more than 7,000 surgeries. Genomic testing and advanced imaging are routine for patients with prostate cancer, providing personalized and precise treatment protocols. 


Advertisement

Advertisement



Advertisement